Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis

BACKGROUND/AIMS: A number of clinical trials reported varying effects of cholesterol lowering agents in nonalcoholic fatty liver disease (NAFLD) patients. We, therefore, assessed the changes in hepatic steatosis and NAFLD activity score (NAS) after treatment with cholesterol lowering agents in NAFLD...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Korean J Intern Med
Main Authors: Lee, Hyo Young, Jun, Dae Won, Kim, Hyun Jung, Oh, Hyunwoo, Saeed, Waqar Khalid, Ahn, Hyeongsik, Cheung, Ramsey C., Nguyen, Mindie H.
Formáid: Artigo
Teanga:Inglês
Foilsithe: The Korean Association of Internal Medicine 2019
Ábhair:
Original Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6406097/
https://ncbi.nlm.nih.gov/pubmed/29551054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2017.194
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla